Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Barris Peter J
Relationship:   Director
City:   Baltimore
State:   MD
   
Insider Summary:
  
   
Companies Owned :   61    
Direct Shares   374,379    

Indirect Shares

   283,825,989      
Direct Value   $4,560,322    

Indirect Value

   $1,355,812,700      
Total Shares   284,200,368      
Total Value   $1,360,373,022      


Vonage Holdings Corp $2,553,224 Innerworkings Inc $106,292 Inteliquent Inc $0 Groupon, Inc. $34,213 Senseonics Holdings Inc $23,560 Sprout Social, Inc. $851,243 Nextnav Inc. $521,839 Zerofox Holdings Ord Shs $469,952 Vonage Holdings Corp $2,553,224 Innerworkings Inc $106,292 Inteliquent Inc $0 Groupon, Inc. $34,213 Senseonics Holdings Inc $23,560 Sprout Social, Inc. $851,243 Nextnav Inc. $521,839 Zerofox Holdings Ord Shs $469,952
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    4    

     Stock price went up :
    0   
    2    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -37.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Welltek Incorporated WTKND Former 10% Owner 0 2004-09-28 14,470    Premium*  
            Aradigm Corp ARDM 10% Owner 2003-12-11 0 2004-02-20 0    Premium*  
            FoxHollow Technologies FOXH Former 10% Owner 2004-11-02 0 2004-11-02 1,804,462    Premium*  
            DZS Inc DZSI 10% Owner 2005-02-10 0 2008-03-10 12,051,646    Premium*  
            Occam Networks Inc OCNW 10% Owner 2006-04-06 0 2006-04-07 0    Premium*  
            Gyre Therapeutics GYRE 10% Owner 2006-04-12 0 2013-12-05 4,563,512    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 2,083,426    Premium*  
            Vonage Holdings Corp VG Director 2012-07-01 121,640 2012-07-01 11,752,903    Premium*  
            Innerworkings Inc INWK Director 2012-05-30 35,549 2012-05-30 4,529,190    Premium*  
            Amicus Therapeutics Inc FOLD 10% Owner 2007-06-05 0 2007-07-25 4,510,340    Premium*  
            Inteliquent Inc IQNT Director 2011-11-16 27,126 2009-06-10 0    Premium*  
            Echo Global Logistics Inc ECHO Director 0 2012-03-05 0    Premium*  
            Financial Engines, Inc. FNGN 10% Owner 0 2010-08-30 3,481,941    Premium*  
            Groupon, Inc. GRPN Director 2022-06-15 24,614 2022-06-15 39,933    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2013-06-03 2,483    Premium*  
            Millennial Media Inc MM 10% Owner 2012-04-03 0 2012-10-29 8,196,614    Premium*  
            Tesaro, Inc. TSRO 10% Owner 2012-07-03 0 2019-01-22 0    Premium*  
            Hyperion Therapeutics Inc HPTX 10% Owner 0 2015-05-07 0    Premium*  
            Audience Inc ADNC 10% Owner 2013-02-15 0 2013-11-05 0    Premium*  
            Workday, Inc. WDAY 10% Owner 2013-04-09 0 2013-04-10 117    Premium*  
            Tableau Software Inc DATA 10% Owner 2013-05-22 0 2014-12-02 69,572    Premium*  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Epizyme, Inc. EPZM 10% Owner 2013-06-05 0 2016-01-12 6,261,599    Premium*  
            Boingo Wireless Inc WIFI 10% Owner 2013-08-21 0 2013-12-11 0    Premium*  
            Glycomimetics Inc GLYC 10% Owner 0 2018-05-10 9,089,041    Premium*  
            Care.com Inc CRCM 10% Owner 2014-01-29 0 2017-11-06 290    Premium*  
            Roka Bioscience, Inc. ROKA 10% Owner 0 2014-07-22 3,216,810    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Viracta Therapeutics Ord Shs VIRX 10% Owner 2014-08-08 0 2014-08-29 4,659,333    Premium*  
            Ardelyx Inc ARDX 10% Owner 2014-12-23 0 2019-12-09 6,564,816    Premium*  
            Box Inc BOX 10% Owner 0 2015-01-28 0    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Supernus Pharmaceuticals Inc SUPN 10% Owner 2015-06-15 0 2015-11-11 212,650    Premium*  
            Nuvelo Inc ABIO 10% Owner 0 2018-02-26 0    Premium*  
            Vitae Pharmaceuticals, Inc VTAE 10% Owner 2015-07-01 0 2015-07-01 1,171    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Xtera Communications, Inc. XCOM 10% Owner 0 2015-11-17 971,733    Premium*  
            Adaptimmune Therapeutics PLC ADAP 10% Owner 0 2018-09-07 12,000,000    Premium*  
            Senseonics Holdings Inc SENS 10% Owner 2017-12-08 48,377 2017-12-08 30,888,266    Premium*  
            Aveo Pharmaceuticals Inc AVEO 10% Owner 0 2019-04-08 25,243,865    Premium*  
            Achaogen Inc AKAO 10% Owner 0 2016-12-19 5,215,128    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2016-10-31 0 2016-10-31 3,490,073    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 0 2018-03-09 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN 10% Owner 2017-07-03 0 2017-07-03 8,140,138    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2019-05-07 2,052,454    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 0 2017-10-10 4,909,956    Premium*  
            Appian Corp APPN 10% Owner 2017-11-20 0 2018-02-13 1,167    Premium*  
            Liquidia Technologies Inc LQDA 10% Owner 2018-07-30 0 2018-07-30 2,484,870    Premium*  
            Elastic N.v. ESTC 10% Owner 2018-10-10 0 2018-10-10 2,197,503    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2019-02-14 0 2019-06-24 7,225,676    Premium*  
            Trevi Therapeutics, Inc. TRVI 10% Owner 2019-05-09 0 2019-05-09 4,438,562    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 0 2019-07-22 4,186,243    Premium*  
            Oyster Point Pharma, Inc. OYST 10% Owner 0 2019-10-30 322,458    Premium*  
            Sprout Social, Inc. SPT Director 2023-05-22 16,873 2023-05-22 99,246    Premium*  
            Revolution Acceleration Acquisit... BGRY 2023-07-20 0 2021-09-27 0    Premium*  
            Nextnav Inc. NN Director 2022-06-22 57,282 2021-12-27 0    Premium*  
            Zerofox Holdings Ord Shs ZFOX Director 2022-12-14 42,918 2022-12-14 0    Premium*  
* Premium Members only  

Records found :    483         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ABIO Nuvelo Inc 10% Owner   –       –       •   2015-06-16 3 IO $0.00 $0 I/I 0 10,221,465 -
ABIO Nuvelo Inc 10% Owner   –       –       •   2018-02-26 4 S $0.50 $731,273 I/I (1,460,209) 0 0 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2016-01-01 3 IO $0.00 $0 I/I 0 59,269,000 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2017-03-27 4 B $0.70 $9,009,000 I/I 12,870,000 72,139,000 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-21 4 B $1.81 $189,820 I/I 104,844 72,243,844 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-22 4 B $1.90 $1,655,669 I/I 869,574 73,113,418 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-23 4 B $1.95 $572,358 I/I 294,090 73,407,508 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-26 4 B $1.90 $1,087,553 I/I 571,164 73,978,672 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-27 4 B $1.92 $11,500,200 I/I 6,000,000 79,978,672 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-09-07 4 B $1.67 $25,000,500 I/I 15,000,000 12,000,000 1.5 -
ADNC Audience Inc 10% Owner   –       –       •   2013-02-15 4 A $0.00 $0 I/I 17,966 2,792 0 -
ADNC Audience Inc 10% Owner   –       –       •   2013-02-15 4 D $0.00 $0 I/I (1,414,000) 0 0 -
ADNC Audience Inc 10% Owner   –       –       •   2013-03-07 4 S $12.96 $36,187 I/I (2,792) 0 0 -
ADNC Audience Inc 10% Owner   –       –       •   2013-11-04 4 D $0.00 $0 I/I (1,453,393) 0 0 -
ADNC Audience Inc 10% Owner   –       –       •   2013-11-04 4 A $0.00 $0 I/I 18,131 2,573 0 -
ADNC Audience Inc 10% Owner   –       –       •   2013-11-05 4 S $9.83 $25,288 I/I (2,573) 0 0 -
AKAO Achaogen Inc 10% Owner   –       –       •   2016-06-03 3 IO $0.00 $0 I/I 0 4,715,128 -
AKAO Achaogen Inc 10% Owner   –       –       •   2016-12-19 4 B $13.50 $6,750,000 I/I 500,000 5,215,128 1.5 -
APPN Appian Corp 10% Owner   –       –       •   2017-11-20 4 A $0.00 $0 I/I 2,820,516 2,820,516 0 -
APPN Appian Corp 10% Owner   –       –       •   2017-11-20 4 S $19.49 $54,971,857 I/I (2,820,516) 0 0 -
APPN Appian Corp 10% Owner   –       –       •   2017-11-27 4 S $19.49 $11,101,894 I/I (569,620) 0 0 -
APPN Appian Corp 10% Owner   –       –       •   2017-11-27 4 A $0.00 $0 I/I 569,620 569,620 0 -
APPN Appian Corp 10% Owner   –       –       •   2018-02-13 4 A $0.00 $0 I/I 42,030 1,167 0 -
APPN Appian Corp 10% Owner   –       –       •   2018-02-13 4 D $0.00 $0 I/I (2,765,065) 0 0 -
APPN Appian Corp 10% Owner   –       –       •   2018-02-13 4 A $0.00 $0 I/I 2,724,202 2,724,202 0 -
  483  Records found
  1  2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20      
  Page 1 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us